Heart rate and cardiovascular mortality: the Framingham Study

scientific article published in June 1987

Heart rate and cardiovascular mortality: the Framingham Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-8703(87)90666-1
P8608Fatcat IDrelease_hge5pi6ozbeatmw3mwdbzpheha
P698PubMed publication ID3591616

P50authorL. Adrienne CupplesQ37638868
William B. KannelQ15439387
P2093author name stringPaffenbarger RS Jr
Kannel C
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectcirculatory systemQ11068
P304page(s)1489-1494
P577publication date1987-06-01
P1433published inAmerican Heart JournalQ2227156
P1476titleHeart rate and cardiovascular mortality: the Framingham Study
P478volume113

Reverse relations

cites work (P2860)
Q38086846'Inappropriate' sinus tachycardia: does the 100 beats per min cut-off matter?
Q569707992007 ESH‐ESC Guidelines for the management of arterial hypertension
Q3493606124-hour autonomic dysfunction and depressive behaviors in an animal model of social isolation: implications for the study of depression and cardiovascular disease
Q91782679A Longitudinal Study of the Association of Clinical Indices of Cardiovascular Autonomic Function with Breast Cancer Treatment and Exercise Training
Q41851953A comparison between heart rate and heart rate variability as indicators of cardiac health and fitness.
Q47827264A genetic analysis of ambulatory cardiorespiratory coupling.
Q38776088A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium
Q81346285A new potential marker for abnormal cardiac physiology in depression
Q24613583A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate
Q57490321A similar 24‐h blood pressure control is obtained by zofenopril and candesartan in primary hypertensive patients
Q37866294A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease.
Q88536384Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently
Q58088698Admission heart rate as a predictor of mortality in patients with acute coronary syndromes
Q47409523Adult height and the risk of cardiovascular disease among middle aged men and women in Japan
Q39164200Advancements in pharmacotherapy for angina.
Q50140868Age-dependent sympathetic neural responses to Β-1 selective beta-blockade in untreated hypertension-related tachycardia.
Q42986821All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy
Q28378188Altered baroreflex control of heart rate in bradykinin B2-receptor knockout mice
Q41435381Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus
Q85738904Analysis of factors related to vagally mediated reflex bradycardia during gastrectomy
Q44630602Anti-Ischemic Effects of Ivabradine, a Selective Heart Rate-Reducing Agent, in Exercise-Induced Myocardial Ischemia in Pigs
Q33533540Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction
Q28291239Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial
Q37672817Antihypertensive effect of barnidipine 10 mg or amlodipine 5 to 10 mg once daily in treatment-naive patients with essential hypertension: A 24-week, randomized, open-label, pilot study.
Q54616735Antihypertensive effects of mibefradil in the treatment of mild-to-moderate systemic hypertension.
Q80810329Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study
Q57488440Antihypertensive efficacy of zofenopril and hydrochlorothiazide combination on ambulatory blood pressure
Q33995658Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality
Q90282403Arrhythmogenic mechanisms of obstructive sleep apnea in heart failure patients
Q47439395Assessing resting heart rate in adolescents: determinants and correlates
Q35684230Assessment of Association of Increased Heart Rates to Cardiovascular Events among Healthy Subjects in the United States: Analysis of a Primary Care Electronic Medical Records Database
Q91705615Association Between Adherence To The French Dietary Guidelines And Lower Resting Heart Rate, Longer Diastole Duration, And Lower Myocardial Oxygen Consumption. The NUTRIVASC Study
Q47892245Association Between Heart Rate and Subclinical Cerebrovascular Disease in the Elderly.
Q37639142Association between Resting Heart Rate and Inflammatory Markers (White Blood Cell Count and High-Sensitivity C-Reactive Protein) in Healthy Korean People.
Q28481738Association between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: cross-sectional study
Q36317496Association between resting heart rate and cardiovascular mortality: evidence from a meta-analysis of prospective studies
Q37324823Association between resting heart rate and coronary artery disease, stroke, sudden death and noncardiovascular diseases: a meta-analysis
Q34795319Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis)
Q51245292Association between resting heart rate, metabolic syndrome and cardiorespiratory fitness in Korean male adults.
Q35011926Association between stressful life events and resting heart rate
Q92366065Association of Antidepressant Medication Type With the Incidence of Cardiovascular Disease in the ARIC Study
Q39667453Association of Heart Rate With Coronary Risk Factors and Increased White Blood Cell Counts in Healthy Japanese People
Q39819895Association of an Index of Healthy Aging With Incident Cardiovascular Disease and Mortality in a Community-Based Sample of Older Adults
Q34017121Association of exercise heart rate response and incidence of hypertension in men.
Q89891134Association of pulse rate with outcomes in heart failure with reduced ejection fraction: a retrospective cohort study
Q35044359Association of resting heart rate with cardiovascular function: a cross-sectional study in 522 Finnish subjects
Q47808175Associations of Insomnia Symptoms With Blood Pressure and Resting Heart Rate: The HUNT Study in Norway
Q40295031Associations of resting heart rate with endothelium-dependent vasodilation and shear rate
Q37306328Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease
Q57309212Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death
Q51294823Attenuated baroreflex sensitivity in normotensive prediabetes and diabetes in Indian adults.
Q27004493Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity
Q36438919Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives
Q58413500Autonomic Stress Response Modes and Ambulatory Heart Rate Level and Variability
Q36765722Autonomic cardiac control in depressed adolescents
Q53624608Autonomic dysfunction assessed by EZSCAN and subclinical atherosclerosis.
Q38170307Beta-blockers and ivabradine in chronic heart failure: from clinical trials to clinical practice.
Q35095473Biological mechanisms in the relationship between depression and heart disease
Q33493202Biological mechanisms of disease and death in Moscow: rationale and design of the survey on Stress Aging and Health in Russia (SAHR)
Q34045097Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.
Q90218632Brain mechanisms of stress and depression in coronary artery disease
Q48223493Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes
Q36632992Cardiac autonomic control and the effects of age, race, and sex: the CARDIA study
Q38202021Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids.
Q37461720Cardiovascular Safety Assessment in Early-Phase Clinical Studies: A Meta-Analytical Comparison of Exposure-Response Models.
Q37562586Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials
Q43963470Cardiovascular alterations and autonomic imbalance in an experimental model of depression
Q34171759Cardiovascular effects of incretin therapy in diabetes care
Q37619664Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment
Q43008709Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power
Q48329640Changes in Heart Rate Variability After Adenotonsillectomy in Children With Obstructive Sleep Apnea
Q36736332Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice
Q90387165Clinical Study Regarding Arrhythmogenic Risk Factors and Oxidative Stress Inductibility in Young People
Q37974156Clinical outcomes in the management of congenital adrenal hyperplasia
Q33610452Clinical presentation and management of stable coronary artery disease in Austria.
Q86450989Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy
Q36292056Cognition and Hemodynamics
Q35581278Combined effects of depressive symptoms and resting heart rate on mortality: the Whitehall II prospective cohort study
Q37976147Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death.
Q47443277Communication and Stress: Effects of Hope Evocation and Rumination Messages on Heart Rate, Anxiety, and Emotions After a Stressor
Q42758573Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise
Q42545413Comparative efficacy and tolerability of two long-acting calcium antagonists, mibefradil and amlodipine, in essential hypertension. Mibefradil Hypertension Study Group
Q50111064Comparison of cardiovascular risk profile between male employees of two automotives companies in France and Sweden. The Coeur Project Group
Q35771801Comparison of endothelial vasodilator function, inflammatory markers, and N-terminal pro-brain natriuretic peptide in patients with or without chronotropic incompetence to exercise test
Q34620940Comparison of the physiologic and prognostic implications of the heart rate versus the RR interval
Q88711747Complementary and Synergic Role of Combined Beta-blockers and Ivabradine in Patients with Chronic Heart Failure and Depressed Systolic Function: A New Therapeutic Option?
Q57316018Complex Segregation Analysis of Blood Pressure and Heart Rate Measured before and after a 20-Week Endurance Exercise Training Program: the Heritage Family Study
Q55687041Concomitant administration of different doses of simvastatin with ivabradine influence on PAI-1 and heart rate in normo- and hypercholesterolaemic rats.
Q36817718Correlates of preclinical cardiovascular disease in Indigenous and Non-Indigenous Australians: a case control study
Q38373654Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcom
Q38697074Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure
Q37230932DNA methylation at birth within the promoter of ANRIL predicts markers of cardiovascular risk at 9 years
Q73932678Depression and coronary heart disease: observations and questions
Q37599875Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications
Q37143291Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms
Q37673237Depressive behavior and coronary artery atherogenesis in adult female cynomolgus monkeys
Q50195061Development and Validation of a New Scoring System to Predict Survival in Patients With Myotonic Dystrophy Type 1.
Q34697669Diabetes, heart rate, and mortality
Q30316590Direct inhibition, but indirect sensitization of pacemaker activity to sympathetic tone by the interaction of endotoxin with HCN-channels
Q44773687Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes?
Q49887583Does resting heart rate measured by the physician reflect the patient's true resting heart rate? White-coat heart rate
Q59913879Dose-dependent increases in heart rate variability and arterial compliance in overweight and obese adults with DHA-rich fish oil supplementation
Q44623356Dyspnoea in chronic primary fibromyalgia
Q34640857Early identification of risk factors for sudden cardiac death
Q54945979Effect of Heart Rate-Oriented Therapy on Diastolic Functions in Patients with Heart Failure with Reduced Ejection Fraction.
Q89868220Effect of Ivabradine on Left Ventricular Diastolic Function, Exercise Tolerance and Quality of Life in Patients With Heart Failure: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
Q33717188Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy
Q36522638Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects
Q51706995Effect of cholinergic blockade on heart rate, blood pressure and plasma catecholamine responses to mental stress in normal subjects
Q37677026Effect of depression and sertraline treatment on cardiac function in female nonhuman primates
Q46574573Effect of diurnal temperature range on cardiovascular markers in the elderly in Seoul, Korea
Q51623318Effect of heart rate on the risk of developing metabolic syndrome.
Q33617828Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials
Q37579594Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease
Q51769228Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
Q37250491Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice
Q92741635Effects of baseline heart rate at sea level on cardiac responses to high-altitude exposure
Q43446368Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials
Q37143356Effects of long-term physical activity on cardiac structure and function: a twin study
Q64885922Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia.
Q43285131Effects of selective I f-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy
Q44954440Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study
Q57316179Electrocardiographic findings in a middle-aged African population in the Seychelles Islands
Q44420051Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology
Q35974310Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long-Term Mortality
Q36041575Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review
Q36035810Elevated heart rate: a major risk factor for cardiovascular disease
Q38689451Elevated resting heart rate is associated with the severity of coronary artery disease in non-treated patients who underwent coronary angiography: potential role of lipoprotein subfractions
Q39678824Elevated resting heart rate is associated with white blood cell count in middle-aged and elderly individuals without apparent cardiovascular disease
Q37827882Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promises
Q38116349Endothelium-dependent control of cerebrovascular functions through age: exercise for healthy cerebrovascular aging
Q37281986Enhanced cardiac TBC1D10C expression lowers heart rate and enhances exercise capacity and survival.
Q24814375Epidemiologic evidence of cardiovascular effects of particulate air pollution
Q26830752Epidemiology of arrhythmias and conduction disorders in older adults
Q46642724Ethnic differences in heart rate: can these be explained by conventional cardiovascular risk factors?
Q72992813Evaluating the safety of mibefradil, a selective T-type calcium antagonist, in patients with chronic congestive heart failure
Q37009578Evaluation of heart rate measurements in clinical studies: a prospective cohort study in patients with heart disease
Q25257902Evidence for a gene influencing heart rate on chromosome 5p13-14 in a meta-analysis of genome-wide scans from the NHLBI Family Blood Pressure Program
Q48783771Exenatide in type 2 diabetes
Q33849850Experimental measurement of dynamic fluid shear stress on the aortic surface of the aortic valve leaflet
Q38065321Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes
Q36823856Factors determining case fatality in myocardial infarction "who dies in a heart attack"?
Q35707442Fiber-based laser speckle imaging for the detection of pulsatile flow
Q48020315Flexible Organic/Inorganic Hybrid Near-Infrared Photoplethysmogram Sensor for Cardiovascular Monitoring
Q33882491Gender and incidence of dementia in the Framingham Heart Study from mid-adult life
Q44003617Gender-specific trends in heart rate in the general population from 1992-2007: a study of 226,288 French adults
Q37216067Genesis and regulation of the heart automaticity.
Q30313100Genetic loci associated with heart rate variability and their effects on cardiac disease risk
Q24624928Genome-wide association analysis identifies multiple loci related to resting heart rate
Q40161459Genome-wide association study of heart rate and its variability in Hispanic/Latino cohorts.
Q57316003Genome-wide linkage scan for submaximal exercise heart rate in the HERITAGE family study
Q36076531Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity
Q48875887Guidelines' criteria for rate control in atrial fibrillation: are they useful?
Q48231366Haemodynamic effects of different basic heart rates in ambulatory heart failure patients treated with cardiac resynchronization therapy
Q50777322Happiness and life satisfaction prospectively predict self-rated health, physical health, and the presence of limiting, long-term health conditions.
Q64248551Heart Rate Is a Better Predictor of Cardiorespiratory Fitness Than Heart Rate Variability in Overweight/Obese Children: The ActiveBrains Project
Q52020956Heart Rate Response to Psychological Stressors of Individuals Possessing Resting Bradycardia
Q39493684Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study.
Q42643848Heart rate and cardiovascular disease: an alternative to Beta blockers
Q37080140Heart rate and ischemic stroke: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
Q38669556Heart rate and its reduction in chronic heart failure and beyond
Q43597755Heart rate and mortality in a Japanese general population: an 18-year follow-up study
Q33985936Heart rate and risk of cancer death in healthy men
Q34281167Heart rate as a cardiovascular risk factor: do women differ from men?
Q28345818Heart rate as a predictor of mortality: the MATISS project
Q34817084Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Q33649639Heart rate as a risk factor for atherosclerosis and cardiovascular mortality: the effect of antihypertensive drugs
Q51830152Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.
Q42923271Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
Q37497745Heart rate as a treatable cardiovascular risk factor
Q36999858Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms
Q40557459Heart rate at admission is a predictor of in-hospital mortality in patients with acute coronary syndromes: Results from 58 European hospitals: The European Hospital Benchmarking by Outcomes in acute coronary syndrome Processes study.
Q51034680Heart rate before ICU discharge: a simple and readily available predictor of short- and long-term mortality from critical illness.
Q51566120Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
Q41969828Heart rate differentiates urgency and emergency in hypertensive crisis
Q85300166Heart rate in coronary artery disease: should we lower it?
Q54414947Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND.
Q35859013Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
Q44799612Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction
Q51734312Heart rate reduction decreases central blood pressure in sick sinus syndrome patients with a permanent cardiac pacemaker.
Q37784463Heart rate reduction in cardiovascular disease and therapy
Q38042855Heart rate reduction in heart failure: ivabradine or beta blockers?
Q57303571Heart rate response during exercise test and cardiovascular mortality in middle-aged men
Q34901289Heart rate variability and experimentally induced pain in healthy adults: a systematic review
Q61659808Heart rate variability associated with particulate air pollution
Q61851313Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel‐group study
Q73798769Heart rate variability in workers exposed to carbon disulfide
Q44602690Heart rate, ejection duration and subendocardial viability ratio in patients with rheumatoid arthritis as compared to controls
Q33613139Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men.
Q92887784Heart rate, mortality, and the relation with clinical and subclinical cardiovascular diseases: results from the Gutenberg Health Study
Q53766023Hemodynamic stress and experimental aortoiliac atherosclerosis.
Q37185043Heritability and linkage study on heart rates in a Mongolian population
Q50267278High prevalence of prehypertension and hypertension in a working population in Hungary
Q46158216Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population
Q62667746How Heart Rate Should Be Controlled in Patients with Atherosclerosis and Heart Failure
Q34560708How lifespan associated genes modulate aging changes: lessons from analysis of longitudinal data
Q91559408Hyperventilation-induced heart rate response as a potential marker for cardiovascular disease
Q92801380Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin
Q40502829Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality
Q47114756If Channel as an Emerging Therapeutic Target for Cardiovascular Diseases: A Review of Current Evidence and Controversies.
Q42861006Impact of ''off-label'' use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure
Q35881505Impact of Heart Rate on Myocardial Salvage in Timely Reperfused Patients with ST-Segment Elevation Myocardial Infarction: New Insights from Cardiovascular Magnetic Resonance.
Q38686536Impact of Narrative Expressive Writing on Heart Rate, Heart Rate Variability, and Blood Pressure After Marital Separation
Q64996381Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population.
Q44584054Impact of diet-induced weight loss on the cardiac autonomic nervous system in severe obesity
Q54328572Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
Q47099826Impact of heart rate in atrial fibrillation versus sinus rhythm on mortality in octogenarian patients with acute coronary syndrome
Q36383760Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy
Q33586456Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).
Q36835335In vivo MRI-based simulation of fatigue process: a possible trigger for human carotid atherosclerotic plaque rupture
Q48743258Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with Heritable OCT1 Deficiency
Q42722402Increased heart rate and atherosclerosis: potential implications of ivabradine therapy
Q54102992Increased heart rate is associated with a prothrombotic state: The Framingham Heart Study.
Q48183900Increased night heart rate is associated with worse large artery elasticity in chronic kidney disease patients.
Q90581238Increased resting heart rate and prognosis in treatment-naïve unselected cancer patients: results from a prospective observational study
Q35419662Increased resting heart rate with pollutants in a population based study
Q28533685Increased risk of sudden cardiac arrest in obstructive pulmonary disease: a case-control study
Q34145473Increased total heart rate variability and enhanced cardiac vagal autonomic activity in healthy humans with sinus bradycardia
Q47569154Influence of heart rate at rest for predicting the metabolic syndrome in older Chinese adults
Q58088640Initial heart rate and cardiovascular outcomes in patients presenting with acute coronary syndrome
Q50660284Integrating New Pharmacologic Agents into Heart Failure Care: Role of Heart Failure Practice Guidelines in Meeting This Challenge.
Q38193910Interaction between heart rate and heart rate variability.
Q34171833Interplay between heart rate and its variability: a prognostic game.
Q38908301Is Heart Rate a Norepiphenomenon in Heart Failure?
Q37992528Is heart rate a treatment target in heart failure?
Q46332953Is there a better way to predict death using heart rate recovery?
Q51738137Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis.
Q34817043Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Q49249173Ivabradine has a neutral effect on mortality in randomized controlled trials
Q43068312Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice
Q50895487Ivabradine in heart failure: NICE guidance.
Q41216543Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration
Q33937346Ivabradine, a novel treatment for clozapine-induced sinus tachycardia: a case series
Q38052022Ivabradine: potential clinical applications in critically ill patients
Q37831353Ivabradine: recent and potential applications in clinical practice
Q33973963Ivabradine: the evidence of its therapeutic impact in angina
Q45913258La fréquence cardiaque au repos : Un indicateur pronostique modifiable du risque et des issues cardiovasculaires ?
Q37694331Late sinus and atrial tachycardia after pediatric heart transplantation might predict poor outcome
Q34920627Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations
Q38295604Long-Term Persistency of Abnormal Heart Rate Variability following Long NICU Stay and Surgery at Birth
Q35021769Long-term cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study
Q52222206Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease.
Q36995719Mechanisms underlying altered mood and cardiovascular dysfunction: the value of neurobiological and behavioral research with animal models
Q34441396Metabolic signatures of exercise in human plasma
Q46225801Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists
Q73739620Mibefradil, a novel calcium antagonist, in elderly patients with hypertension: favorable hemodynamics and pharmacokinetics
Q37399776Mind and body: how the health of the body impacts on neuropsychiatry.
Q34573112Morbidity and mortality in cardiovascular disorders: impact of reduced heart rate
Q39038606Murine Electrophysiological Models of Cardiac Arrhythmogenesis
Q35544382Nemaline myopathy and heart failure: role of ivabradine; a case report
Q33363027Nighttime heart rate and survival in depressed patients post acute myocardial infarction
Q37250248Nocturnal nondipping of heart rate predicts cardiovascular events in hypertensive patients
Q38529981Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome
Q42759095Obesity: weighing the risk before prescribing
Q31052717Office and 24-hour heart rate and target organ damage in hypertensive patients
Q38233967Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors
Q24187704Pharmacological interventions for clozapine-induced sinus tachycardia
Q26471506Pharmacological interventions for clozapine-induced sinus tachycardia
Q33611732Physical activity and ischaemic heart disease in middle-aged British men.
Q60949807Physical activity may compensate for prolonged TV time regarding pulse rate-a cross-sectional study
Q33772041Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes
Q50538874Positive association between resting pulse and cancer incidence in current and former smokers.
Q33545059Potential interests of heart rate lowering drugs
Q74484776Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry)
Q50213542Predicting Coronary Atherosclerotic Plaque Burden From Clinical Parameters: Bringing Old Knowledge in the Game
Q36441990Predicting mortality and rehospitalization in heart failure patients with home monitoring--the Home CARE pilot study
Q91606722Predicting tachycardia as a surrogate for instability in the intensive care unit
Q37374631Predictive value of night-time heart rate for cardiovascular events in hypertension. The ABP-International study
Q35684003Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction
Q90095011Prognostic value of discharge heart rate in acute heart failure patients: More relevant in atrial fibrillation?
Q36249527Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort
Q37537663Protective role of resting heart rate on all-cause and cardiovascular disease mortality
Q37510667Pulse contour cardiac output monitoring in acute heart failure patients : Assessment of hemodynamic measurements
Q85648282Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from the GOOD survey
Q43662606Pulse pressure and heart rate: independent risk factors for cancer?
Q75239566Pulse rate in childhood: reference limits
Q79345669QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up
Q46051385Rapid resting heart rate: a simple and powerful predictor of osteoporotic fractures and mortality in older women
Q37810893Rate control with ivabradine: angina pectoris and beyond
Q91869970Real-world heart rate norms in the Health eHeart study
Q41653534Reappraisal of the importance of heart rate as a risk factor for cardiovascular morbidity and mortality
Q72561230Recalibration of normal sinus heart rate: clinical thinking and epidemiologic support
Q46239241Reduced intrinsic heart rate is associated with reduced arrhythmic susceptibility in guinea-pig heart
Q36355384Reduction of heart rate by omega-3 fatty acids and the potential underlying mechanisms
Q39083296Relation of Birth Weight to Heart Rate in Childhood, Adolescence, and Adulthood (from the Bogalusa Heart Study).
Q30420730Relation of left ventricular mass at age 23 to 35 years to global left ventricular systolic function 20 years later (from the Coronary Artery Risk Development in Young Adults study)
Q42859076Relationship between resting electrocardiographic parameters and estimated 10-year risk for coronary heart disease in healthy adults in the USA.
Q35599690Relationship of resting heart rate and physical activity with insulin sensitivity in a population-based survey
Q34028226Relevance of heart rate as a risk factor in hypertension
Q50019775Resting Heart Rate Trajectory Pattern Predicts Arterial Stiffness in a Community-Based Chinese Cohort
Q37643822Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study
Q45187664Resting Heart Rate as a Predictor of Body Weight Gain in the Early Stage of Hypertension
Q34400715Resting heart rate and risk of cardiovascular diseases and all-cause death: the Kailuan study
Q34345139Resting heart rate and risk of sudden cardiac death in the general population: influence of left ventricular systolic dysfunction and heart rate-modulating drugs
Q37092311Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study
Q40614123Resting heart rate as a prognostic factor for mortality in patients with breast cancer
Q43476890Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information?
Q33682532Resting heart rate as predictor for left ventricular dysfunction and heart failure: MESA (Multi-Ethnic Study of Atherosclerosis).
Q34633143Resting heart rate in first year survivors of myocardial infarction and long-term mortality: a community study
Q34089856Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumonia
Q40955114Resting heart rate is an independent predictor of all-cause mortality in the middle aged general population
Q48745127Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study
Q41759015Resting heart rate on the decline: the Tromsø Study 1986-2007.
Q40867546Resting heart rate predicts incident myocardial infarction, atrial fibrillation, ischaemic stroke and death in the general population: the Tromsø Study
Q34774214Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?
Q45751138Resting, night-time, and 24 h heart rate as markers of cardiovascular risk in middle-aged and elderly men and women with no apparent heart disease
Q31127047Risk-adjustment models for heart failure patients' 30-day mortality and readmission rates: the incremental value of clinical data abstracted from medical charts beyond hospital discharge record
Q33568592Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
Q37986643Role of heart rate as a marker and mediator of poor outcome for patients with heart failure
Q35771528Secular trends in heart rate in young adults, 1949 to 2004: analyses of cross sectional studies
Q37111971Silencing of the Drosophila ortholog of SOX5 in heart leads to cardiac dysfunction as detected by optical coherence tomography
Q28179461Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven?
Q38934152Sinus tachycardia is associated with impaired exercise tolerance following heart transplantation.
Q45984849Sleep-disordered breathing and daytime cardiac conduction abnormalities on 12-lead electrocardiogram in community-dwelling older men.
Q48737333Sleep-related breathing disorder is an independent risk factor for systemic hypertension
Q47327059Smartphone accelerometers for the detection of heart rate
Q35185550Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women.
Q44105224Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring
Q50531179Spot the red herring: breastfeeding, fruitpurée, and infant autonomic functioning-the generation R study.
Q37035595Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models
Q33711111Stress, depression, and coronary artery disease: modeling comorbidity in female primates
Q34345278Subclinical albuminuria is linked to gray matter atrophy in type 2 diabetes mellitus
Q37076040Submaximal Exercise Systolic Blood Pressure and Heart Rate at 20 Years of Follow-up: Correlates in the Framingham Heart Study
Q34261790Sudden cardiac death and inherited channelopathy: the basic electrophysiology of the myocyte and myocardium in ion channel disease
Q35767296Sudden cardiac death in patients with diabetes
Q36861254Sudden unexpected cardiac death as a function of time since the detection of electrocardiographic and clinical risk factors in apparently healthy men: the Manitoba Follow-Up Study, 1948 to 2004.
Q38837789Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies.
Q37200209Targeted ablation of cardiac sympathetic neurons reduces resting, reflex and exercise-induced sympathetic activation in conscious rats
Q34980432Testing a workplace physical activity intervention: a cluster randomized controlled trial
Q35803317Testing an association between baseline resting pulse rate averages and short-term changes in resting pulse rates: A pilot study.
Q89522021The Association Between Heart Rate and Glycemic Status in the National Health and Nutrition Examination Surveys
Q36228671The Association of Resting Heart Rate with the Presence of Diabetes in Korean Adults: The 2010-2013 Korea National Health and Nutrition Examination Survey
Q83193283The BEAUTIFUL study: is heart rate reduction a new therapeutic principle?
Q46506630The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population
Q36822268The Effect of Resting Heart Rate on the New Onset of Microalbuminuria in Patients With Type 2 Diabetes: A Subanalysis of the ROADMAP Study
Q92377672The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Q26741956The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients
Q35227472The Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular Health
Q34332916The beta blockers: are they as protective in hypertension as in other cardiovascular conditions?
Q35665387The broken heart: noninvasive measurement of cardiac autonomic tone
Q35162676The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression
Q93157484The cardiovascular phenotype of adult patients with phenylketonuria
Q80159976The effect of 4-week chilli supplementation on metabolic and arterial function in humans
Q37125667The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study
Q88451108The effects of heart rate control in chronic heart failure with reduced ejection fraction
Q38669129The efficacy of continuous positive airway pressure therapy in reducing cardiovascular events in obstructive sleep apnea: a systematic review
Q35787800The factor-of-risk biomechanical approach predicts hip fracture in men and women: the Framingham Study
Q37749825The future of aerobic exercise testing in clinical practice: is it the ultimate vital sign?
Q90299460The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
Q37739848The prognostic significance of heart rate for cardiovascular disease and hypertension
Q68471205The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease
Q89274861The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study
Q34981000The role of cardiac autonomic function in hypertension and cardiovascular disease
Q46621008The role of heart rate reduction in angina management and beyond
Q58568726The therapeutic role of ivabradine in heart failure
Q37118708Thyroid hormone levels within reference range are associated with heart rate, cardiac structure, and function in middle-aged men and women
Q86747842Unaltered R-R interval variability and bradycardia in cyclists as compared with non-athletes
Q92180650Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study
Q64966612Using heart rate profiles during sleep as a biomarker of depression.
Q34860874Variation in resting heart rate over 4 years and the risks of myocardial infarction and death among older adults
Q28384493Very Long (> 48 hours) Shifts and Cardiovascular Strain in Firefighters: a Theoretical Framework
Q37116321When heart goes "BOOM" to fast. Heart rate greater than 80 as mortality predictor in acute myocardial infarction
Q33752515Where are we going with SSRIs?
Q37615411Why are well-educated Muscovites more likely to survive? Understanding the biological pathways
Q74013274Women with high exercise tolerance and the role of myocardial perfusion imaging
Q73353152[Heart rate and isolated clinical tachycardia in hypertensive patients]
Q83198023[Susceptibility to atherosclerosis in patients with psoriasis and psoriatic arthritis as determined by carotid-femoral (aortic) pulse-wave velocity measurement]
Q33160305β-1 and β-2 adrenergic receptor polymorphism and association with cardiovascular response to orthostatic screening
Q37822723β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease
Q48096584β1 -Adrenoceptor, but not β2 -adrenoceptor, subtype regulates heart rate in type 2 diabetic rats in vivo.

Search more.